Neuroone Medical Technologies (NMTC) Return on Capital Employed (2016 - 2025)
Historic Return on Capital Employed for Neuroone Medical Technologies (NMTC) over the last 11 years, with Q4 2025 value amounting to 0.91%.
- Neuroone Medical Technologies' Return on Capital Employed rose 6500.0% to 0.91% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.91%, marking a year-over-year increase of 6500.0%. This contributed to the annual value of 0.73% for FY2025, which is 19000.0% up from last year.
- Neuroone Medical Technologies' Return on Capital Employed amounted to 0.91% in Q4 2025, which was up 6500.0% from 0.5% recorded in Q3 2025.
- In the past 5 years, Neuroone Medical Technologies' Return on Capital Employed ranged from a high of 0.5% in Q3 2025 and a low of 4.06% during Q3 2024
- Its 5-year average for Return on Capital Employed is 1.6%, with a median of 1.22% in 2021.
- Its Return on Capital Employed has fluctuated over the past 5 years, first crashed by -19900bps in 2021, then skyrocketed by 35600bps in 2025.
- Quarter analysis of 5 years shows Neuroone Medical Technologies' Return on Capital Employed stood at 0.95% in 2021, then increased by 4bps to 0.91% in 2022, then crashed by -168bps to 2.43% in 2023, then soared by 36bps to 1.56% in 2024, then soared by 42bps to 0.91% in 2025.
- Its Return on Capital Employed stands at 0.91% for Q4 2025, versus 0.5% for Q3 2025 and 0.91% for Q2 2025.